Skip to content

Effect of physical activity and supplementation on BDNF index

The effect of 6 weeks of high-intensity interval training (HIIT) with supplementation of Omega-3 on serum levels of brain-derived neurotrophic factor (BDNF) in sedentary male students

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181227042149N1
Enrollment
40
Registered
2019-02-23
Start date
2018-09-23
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy people.

Interventions

Intervention 1: Control group: During this 6-week period, no activity will be involved, nor will any use be made. Intervention 2: First Intervention group: High-Intensity interval training (40 m round

Sponsors

The University of Sistan and Baluchestan
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Completion of consent form for cooperation in research work. Non-public physical education physical education male students that have 1 to select units. Subjects do not have regular physical activity during the last 6 months. At least 6 months before the start of the study, they did not use omega-3 supplements, antioxidants or certain medications. Lack of specific disease and having physical health of subjects. Non-use of cigarettes and tobacco.

Exclusion criteria

Exclusion criteria: Physical Education Students or Students who Have Elected Physical Education 2. Failure to complete the consent form for cooperation in the research project. Subjects with respiratory, cardiac or other diseases. Subjects use a specific drug or supplement 6 months before or at the present time. Subjects have regular activities such as walking, bodybuilding, soccer and ... in the last 6 months or now. Smoking or tobacco use.

Design outcomes

Primary

MeasureTime frame
Serum levels of Brain-derived neurotrophic factor (BDNF). Timepoint: Measuring serum BDNF levels at the beginning of the study 24 hours before the start of the The first session of the training and at the end (6 weeks) 48 hours after the last training session. Method of measurement: Blood serum sampling-Laboratory kit for serum human BDNF.

Secondary

MeasureTime frame
Hematology Indicators. Timepoint: At the beginning of the study, 24 hours before the start of the protocol and at the end of the protocol (6 weeks), 48 hours after the last session of the protocol. Method of measurement: American Sysemox Electron Microscope.;Weight. Timepoint: At the beginning of the study, 24 hours before the start of the protocol and at the end of the protocol (6 weeks), 48 hours after the last session of the protocol. Method of measurement: German Seca Digital Scale.;Blood pressure. Timepoint: At the beginning of the study, 24 hours before the start of the protocol and at the end of the protocol (6 weeks), 48 hours after the last session of the protocol. Method of measurement: Pressure gauge Japanese ALPK2.;Body fat percentage. Timepoint: At the beginning of the study, 24 hours before the start of the protocol and at the end of the protocol (6 weeks), 48 hours after the last session of the protocol. Method of measurement: Japan's Caliph Yagamy.;Maximum Oxygen Consumption. Timepoint: At the beginning of the study, 24 hours before the start of the protocol and at the end of the protocol (6 weeks), 48 hours after the last session of the protocol. Method of measurement: Test a mile running in the field.;Body mass index. Timepoint: Measuring serum BDNF levels at the beginning of the study, 24 hours before the start of the protocol and at the end of the protocol (6 weeks), 48 hours after the last session of the protocol. Method of measurement: Digital scales and gauges German Seca Model.;Waist to hip. Timepoint: ???At the beginning of the study, 24 hours before the start of the protocol and at the end of the protocol (6 weeks), 48 hours after the last session of the protocol. Method of measurement: Strip meter.;Lipid Profiles. Timepoint: ???At the beginning of the study, 24 hours before the start of the protocol and at the end of the protocol (6 weeks), 48 hours after the last session of the protocol. Method of measurement: Blood serum sampling, Speci

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSajjad karimi pour

The University of Sistan and Baluchestan

info@usb.ac.ir+98 54 3113 6456

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026